Results 41 to 50 of about 842,511 (301)

Approaches for predicting long-term sickness absence. Re: Schouten et al. “Screening manual and office workers for risk of long-term sickness absence: cut-off points for the Work Ability Index”

Scandinavian Journal of Work, Environment & Health, 2015
We read with much interest the article of Schouten et al (1) on identifying workers with a high risk for future long-term sickness absence using the Work Ability Index (WAI).
Ludovic GPM van Amelsvoort, Nicole WH Jansen, IJmert Kant   +2 more
doaj   +1 more source

Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis

Arthritis Research & Therapy, 2019
Following publication of the original article [1], the authors reported an error in the affiliation of Ari Polachek.
Ari Polachek, Richard Cook, Vinod Chandran, Dafna D. Gladman, Lihi Eder   +4 more
doaj   +1 more source

Re: Amelsvoort et al. “Approaches for predicting long-term sickness absence”

Scandinavian Journal of Work, Environment & Health, 2015
We would like to thank Van Amelsvoort et al (1) for the interest in our study (2) and take the opportunity to clarify here that none of the workers were sick-listed when they participated in the baseline health survey.
Lianne S Schouten, Catelijne I Joling, Joost WJ van der Gulden, Martijn W Heymans, Ute Bültmann, Corné AM Roelen   +5 more
doaj   +1 more source

Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer [PDF]

Journal of Cancer, 2021
Ovarian cancer is a serious threat to women's health; its early diagnosis rate is low and prone to metastasis and recurrence. The current conventional treatment for ovarian cancer is a combination of platinum and paclitaxel chemotherapy based on surgery.
Liu, Shuna, Wu, Ming, Wang, Fang
openaire   +2 more sources

Standardizing research methods for prognostics [PDF]

2008 International Conference on Prognostics and Health Management, 2008
Prognostics and health management (PHM) is a maturing system engineering discipline. As with most maturing disciplines, PHM does not yet have a universally accepted research methodology. As a result, most component life estimation efforts are based on ad-hoc experimental methods that lack statistical rigor.
Uckun, S., Goebel, K., Lucas, P.J.F.
openaire   +2 more sources

Homeopathic Remedies in COVID-19: Prognostic Factor Research [PDF]

Homeopathy, 2021
AbstractBackground/Objective Coronavirus disease 2019 (COVID-19) is a new disease; its clinical profile and natural history are evolving. Each well-recorded case in homeopathic practice is important for deciding the future course of action. This study aims at identifying clinically useful homeopathic remedies and their prescribing symptoms using the ...
Raj Kumar Manchanda, Anjali Miglani, Meeta Gupta, Baljeet Singh Meena, Vishal Chadha, Franco Joseph, Amrit Kalsi, Pramod Konthembath, Kavita Sharma, Kamsali Nadigadda Rama, Prabhjeet Kaur, Jithesh Thavarayil Kannoth, Cheshta Nagrath, Anju Jethani, Shajimol Nellikka Aniyeri, Anu Chawla, Malaya Kumar Ray, Manjula Ghuliani, Ram Kumar Kudiyarasu, Shruti Naskar, Sudha Bala, Brender Sharma   +21 more
openaire   +2 more sources

Circulating tumor cells as prognostic biomarkers in glioblastoma.

, 2021
Background: Glioblastoma (GBM) is the most common and aggressive type of tumor arising from the central nervous system. GBM remains an incurable disease despite current advancement in therapies, with survival rates of approximately 15 months.
Chua, Benjamin, Warkiani, Majid E, Punyadeera, Chamindie, Hartel, Gunter, Kulasinghe, Arutha, Leo, Paul, Jeffree, Rosalind L, Bark, Juliana Muller, Day, Bryan W   +8 more
core   +1 more source

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort. [PDF]

, 2012
BACKGROUND: The natural history of prostate cancer is highly variable and it is difficult to predict. We showed previously that a cell cycle progression (CCP) score was a robust predictor of outcome in a conservatively managed cohort diagnosed by ...
Younus, A, Stone, S, M Perry, Mesher, D, A Gutin, J S Lanchbury, Scardino, P, H Møller, A Younus, Gutin, A., J Park, Stone, S., Cuzick, J, D M Berney, Lanchbury, JS, D Mesher, Scardino, P., Mesher, D., J Cuzick, Berney, D. M., Moller, H.; id_orcid, Cuzick, J., Reid, JE, Lanchbury, J. S., Berney, DM, Fisher, G., Perry, M, Transatlantic Prostate Group, P Scardino, S Stone, Foster, C. S., Fisher, G, Møller, H, Foster, CS, Reid, J. E., G Fisher, C S Foster, Younus, A., J E Reid, Park, J., Gutin, A, Park, J, Perry, M.   +42 more
core   +1 more source

An external validation of the Kidney Donor Risk Index in the UK transplant population in the presence of semi-competing events

Diagnostic and Prognostic Research, 2023
Background Transplantation represents the optimal treatment for many patients with end-stage kidney disease. When a donor kidney is available to a waitlisted patient, clinicians responsible for the care of the potential recipient must make the decision ...
Stephanie Riley, Kimberly Tam, Wai-Yee Tse, Andrew Connor, Yinghui Wei   +4 more
doaj   +1 more source

Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome

, 2013
Renal cell carcinoma (RCC) is the most deadly of urological malignancies. Metastatic disease affects one third of patients at diagnosis with a further third developing metastatic disease after extirpative surgery.
Antony C P Riddick, Stewart Grant D., Laird Alexander, Alexander Laird, Grant D Stewart, Laird, Alexander, O'Mahony, Fiach C, Riddick, Antony C P, Riddick Antony C. P., O’Mahony Fiach C., Harrison David J., Fiach C O'Mahony, Jyoti Nanda, Harrison, David J, David J Harrison, O'Mahony, Fiach C., Riddick, Antony C. P., Nanda Jyoti, Nanda, Jyoti, Stewart, Grant D., O’Donnell Marie, O'Donnell, Marie, Stewart, Grant D, Marie O'Donnell, Harrison, David J.   +24 more
core   +1 more source